These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16171872)

  • 1. Novel signal transduction modulators for the treatment of airway diseases.
    Barnes PJ
    Pharmacol Ther; 2006 Jan; 109(1-2):238-45. PubMed ID: 16171872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD: current therapeutic interventions and future approaches.
    Barnes PJ; Stockley RA
    Eur Respir J; 2005 Jun; 25(6):1084-106. PubMed ID: 15929966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
    Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
    Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD: is there light at the end of the tunnel?
    Barnes PJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG; Rajagopal D; Ray A
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a future for small molecule drugs in the treatment of rheumatic diseases?
    Stanczyk J; Ospelt C; Gay S
    Curr Opin Rheumatol; 2008 May; 20(3):257-62. PubMed ID: 18388515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
    Blease K; Raymon HK
    Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid effects on cell signalling.
    Barnes PJ
    Eur Respir J; 2006 Feb; 27(2):413-26. PubMed ID: 16452600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nerve growth factor and its receptors in airway inflammatory diseases.
    Freund-Michel V; Frossard N
    Pharmacol Ther; 2008 Jan; 117(1):52-76. PubMed ID: 17915332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.